Testing a new surgical headset for brain and reconstructive surgeries
Part of Cancer clinical trials.
This trial tests a new headset that helps surgeons see better during certain brain surgeries and reconstructive surgeries. It looks at two types of procedures: one for brain tumors (using a dye called 5-ALA) and one for blood vessel problems in the brain or reconstructive surgery (using a dye called ICG).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You need to be having a brain surgery or reconstructive surgery (like for blood vessels).
- If you are having a brain tumor surgery, the tumor must be a suspected high-grade glioma (WHO grade III or IV), and you will be given a fluorescent dye called 5-ALA before surgery.
- If you are having brain blood vessel or reconstructive surgery, you will be given a dye called Indocyanine Green (ICG) during surgery.
- You cannot have a severe allergy to the dyes used (5-ALA or ICG) or to iodine-based substances (like contrast dye used in CT scans).
- You cannot be a United States citizen.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special fluorescent dye (FG001) that helps surgeons see and remove high-grade brain tumors more completely during surgery. The dye is injected before surgery and glows under special light, potentially helping surgeons remove more tumor tissue safely.
This study tests the GLOW800 device which uses a special dye (ICG) to help surgeons see blood flow during brain or reconstructive surgery. It aims to confirm the device works as intended.
This study tests a special imaging device used during brain tumor removal surgery. The device uses a fluorescent dye to help the surgeon see high-grade glioma (a type of brain tumor) more clearly. It aims to collect data on the device's performance and safety.
This study is testing whether a special dye called 5-ALA can help doctors see brain tumors more clearly during surgery. You may be able to join if you are scheduled for surgery to remove a suspected high-grade glioma.
This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.
This trial tests a device (CCeLL-In Vivo) that may help surgeons tell tumor from normal brain tissue during an operation, which could improve how much tumor is removed while protecting healthy brain.
Hear when a new High-Grade Glioma (WHO III-IV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.